Partners will develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic... Sep 30
China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial.... Sep 29
The study will enrol up to 40 patients into two cohorts, randomized 1:1 to receive the active study drug plus standard treatment or placebo... Sep 29
150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.... Sep 28
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield reagent and collection devices. ... Sep 28
The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ... Sep 26
VMS, is commonly known as hot flashes and night sweats, in menopausal women.... Sep 26
Russia pushes the cheapest covid drug Avifavir... Sep 25
Manufacturing agreement is for Vivet’s Investigational Gene Therapy for Wilson Disease... Sep 24
Latest Pharma acquisation news Sep 23, 2020... Sep 23
... Sep 23
Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform ... Sep 23
Drug combo cuts recurrence risk of breast cancer by 25%... Sep 21
... Sep 19
Zydus Cadila has received final approval from the USFDA to market Potassium Chloride Extended-Release Tablets... Sep 19
Cervical cancer detection gets new tests for early diagonosis... Sep 18
Under the terms of the agreement, Moderna will lead discovery efforts, leveraging its leading mRNA technology and delivery platforms along with Chiesi’s expertise in ... Sep 18
Now samples do not have to reach Singapore for evaluation... Sep 17
End-to-end solution and components offer flexibility to testing facilities, meeting high-volume demand and significantly boosting global testing capacity ... Sep 16
Lesser drug recalls with DSCSA supply chain... Sep 16
Novavax aims for 2 billion COVID-19 vaccine doses with expanded Serum Institute, India deal ... Sep 16
GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
ACTO cements its position as the largest life sciences commercial learning and development platform ... Sep 15
Another Indian company joins Remdesivir production... Sep 15
Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) platform exclusive license from Sorento... Sep 15
-Advertisements-
Thursday, May 16, 2024
.jpg)
